Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Takeda Pharmaceutical's pe ratio was 75.6× on May 29, 2026, against 47.5× a year earlier. Over the last 5 years it ranged from 12.7× to 87.6×, with a median of 28.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | May 29, 2026 | 75.6× | +2.9 |
| 2025 | Dec 31, 2025 | 72.7× | +27.0 |
| 2024 | Dec 31, 2024 | 45.7× | +25.8 |
| 2023 | Dec 29, 2023 | 19.9× | −8.3 |
| 2022 | Dec 30, 2022 | 28.2× | +15.1 |
| 2021 | Dec 31, 2021 | 13.1× | −119.8 |
| 2020 | Dec 31, 2020 | 133.0× | +102.3 |
| 2019 | Dec 31, 2019 | 30.7× | +15.1 |
| 2018 | Dec 31, 2018 | 15.5× | −28.3 |
| 2017 | Dec 29, 2017 | 43.8× | – |